Matching targeted therapies to gene mutations improves survival
Matching targeted therapies to tumor-specific gene mutations across tumor types improved survival in patients with advanced cancer,...
Drug may benefit urinary tract cancer patients
In recent years, five new immunotherapy drugs have been approved to treat patients diagnosed with urinary cancer. But the drugs, which...
Could a pill replace chemotherapy for some patients?
In a small Phase II study of early-stage breast cancer patients with BRCA 1 and 2 mutations, researchers found that more than half of...
PARP inhibitor shows benefit for small cell lung cancer patients
In a randomized, Phase II trial led by researchers at MD Anderson, adding the PARP inhibitor veliparib to a standard chemotherapy...
Together, chemo and proton therapy lengthen survival for...
For patients with advanced, inoperable stage 3 lung cancer, chemotherapy and a specialized form of radiation treatment known...
Two combination therapies shrink melanoma brain metastases...
High response rates to a pair of combination therapies point to potentially new options for a group of metastatic melanoma patients...
Advanced radiation technique shows promise for lung cancer...
An advanced form of image-guided radiation therapy known as intensity modulated proton therapy (IMPT) has shown early promise for the...
Chemotherapy may not be necessary for early-stage breast...
A new study from MD Anderson finds that women with early-stage breast cancer who had an intermediate risk recurrence score (RS)...
Hormone therapy shows big promise for ovarian cancer...
For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma (LGSC), hormone...
Study links contralateral breast cancer with dense tissue
Breast cancer patients with dense breast tissue have almost a two-fold increased risk of developing disease in the other breast,...